What's breaking now, across thousands of outlets.
A UCLA-led team has described how it advanced an experimental CRISPR approach for sickle cell disease into a blood stem cell therapy that can be manufactured at the scale and quality required for a clinical trial.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
Key PointsMedicare's open enrollment runs through Dec. 7.
Reading emotions from body language and facial expressions helps people navigate social life. A study in Germany found that men with schizophrenia were less accurate at both, using displays in which…
Opinion: Group medical visits play a key role in reducing the burden of care on other parts of the health system. Restricting them will not reduce demand for care but will harm patients and strain…
Young people and women most at risk, study finds, as researchers call for vegan products to be fortified with iodine in particular Switching from dairy products to plant-based alternatives could lead…
Rockefeller scientists have created the most comprehensive map to date of how essential genes interact in Mycobacterium tuberculosis (Mtb), the bacterium responsible for tuberculosis (TB).
